Newsletter Archive
-
04.15.26 -- Defining Potency In The mRNA Space
4/15/2026
04/15/26 Advancing RNA Newsletter
-
04.08.26 -- Fact Checking The "Death" Of The US mRNA Industry
4/8/2026
04/08/26 Advancing RNA Newsletter
-
04.04.26 -- Advancing RNA Newsletter Best Of March
4/4/2026
04/04/26 Advancing RNA Newsletter
-
04.01.26 -- The Evolving CMC Landscape For mRNA-LNPs
4/1/2026
04/01/26 Advancing RNA Newsletter
-
03.25.26 -- Benchmarking RNA Delivery Performance: Toward Standardized Metrics For Translational Success
3/25/2026
03/25/26 Advancing RNA Newsletter
-
03.18.26 -- The 2026 RNA Investment Landscape
3/18/2026
03/18/26
-
03.11.26 -- RNA Delivery Technologies: Industrial Applications & Emerging Innovations
3/11/2026
03/11/26 Advancing RNA Newsletter
-
03.09.26 -- Looking Ahead In Oligonucleotide Manufacturing
3/9/2026
03/09/26 Advancing RNA Newsletter
-
03.07.26 -- Advancing RNA Newsletter Best Of February
3/7/2026
03/07/26 Advancing RNA Newsletter
-
03.04.26 -- mRNA Hot Takes: Fighting Complacency & "Alternative Facts"
3/4/2026
03/04/26 Advancing RNA Newsletter